| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6117686 | International Journal of Antimicrobial Agents | 2015 | 6 Pages |
Abstract
- Use of temocillin in patients treated by intermittent haemodialysis was evaluated.
- Based on PK data, temocillin is a reliable option to treat Gram-negative infections in this setting.
- Temocillin parenteral therapy on dialysis days only is suitable for inpatients and outpatients.
- Doubling the recommended dose is needed to reach appropriate temocillin exposure.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Stefaan J. Vandecasteele, Ana C. Miranda Bastos, Arnaud Capron, Anne Spinewine, Paul M. Tulkens, Françoise Van Bambeke,